Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Linke

Showing results (331-340 of 444) with videos related to

Pageof 45
Sort By:
American Heart Journal|July 17, 2012
The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions RegistryJan-Malte Sinning, Martin Horack, Eberhard Grube, et al.
Journal of Clinical Medicine|March 11, 2023
Impact of <i>Enterococci</i> vs. <i>Staphylococci</i> Induced Infective Endocarditis after Transcatheter Aortic Valve ImplantationTomasz Gasior, Felix J Woitek, Antonia Schroth, et al.
Lancet (London, England)|October 2, 2019
Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trialJonas Lanz, Won-Keun Kim, Thomas Walther, et al.
JACC. Cardiovascular Imaging|October 17, 2021
Predictors of Prosthetic Valve Regurgitation After Transcatheter Aortic Valve Implantation With ACURATE neo in the SCOPE I TrialWon-Keun Kim, Thomas Walther, Christof Burgdorf, et al.
Journal of the American Heart Association|October 24, 2019
Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III TrialChristopher U Meduri, Dean J Kereiakes, Vivek Rajagopal, et al.
JAMA Network Open|October 27, 2022
Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical TrialDavid G Rizik, Vivek Rajagopal, Raj R Makkar, et al.
Lancet (London, England)|September 2, 2018
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trialRaban V Jeger, Ahmed Farah, Marc-Alexander Ohlow, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 7, 2019
Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trialRobert Zilberszac, Rishi Chandiramani, Christian Hengstenberg, et al.
Lancet (London, England)|November 15, 2011
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trialGiulio G Stefanini, Bindu Kalesan, Patrick W Serruys, et al.
Lancet (London, England)|September 4, 2008
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trialStephan Windecker, Patrick W Serruys, Simon Wandel, et al.
Pageof 45

Showing results (331-340 of 444) with videos related to

Sort By:
Pageof 45
American Heart Journal|July 17, 2012
The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions RegistryJan-Malte Sinning, Martin Horack, Eberhard Grube, et al.
Journal of Clinical Medicine|March 11, 2023
Impact of <i>Enterococci</i> vs. <i>Staphylococci</i> Induced Infective Endocarditis after Transcatheter Aortic Valve ImplantationTomasz Gasior, Felix J Woitek, Antonia Schroth, et al.
Lancet (London, England)|October 2, 2019
Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trialJonas Lanz, Won-Keun Kim, Thomas Walther, et al.
JACC. Cardiovascular Imaging|October 17, 2021
Predictors of Prosthetic Valve Regurgitation After Transcatheter Aortic Valve Implantation With ACURATE neo in the SCOPE I TrialWon-Keun Kim, Thomas Walther, Christof Burgdorf, et al.
Journal of the American Heart Association|October 24, 2019
Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III TrialChristopher U Meduri, Dean J Kereiakes, Vivek Rajagopal, et al.
JAMA Network Open|October 27, 2022
Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical TrialDavid G Rizik, Vivek Rajagopal, Raj R Makkar, et al.
Lancet (London, England)|September 2, 2018
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trialRaban V Jeger, Ahmed Farah, Marc-Alexander Ohlow, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 7, 2019
Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trialRobert Zilberszac, Rishi Chandiramani, Christian Hengstenberg, et al.
Lancet (London, England)|November 15, 2011
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trialGiulio G Stefanini, Bindu Kalesan, Patrick W Serruys, et al.
Lancet (London, England)|September 4, 2008
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trialStephan Windecker, Patrick W Serruys, Simon Wandel, et al.
Pageof 45